Cooper D, Moisan J, Abdous B, Grégoire J-P. A POPULATION-BASED COST-EFFECTIVENESS ANALYSIS OF OLANZAPINE AND RISPERIDONE AMONG AMBULATORY PATIENTS WITH SCHIZOPHRENIA. J Popl Ther Clin Pharmacol [Internet]. 2018 Dec. 8 [cited 2024 Nov. 19];15(3). Available from: https://mail.jptcp.com/index.php/jptcp/article/view/229